Medical Device Global Market Access

Pure Global
  • 5.0 (1)
  • Technology

Navigate every market. Accelerate every launch. Medical Device Global Market Access by Pure Global is the audio briefing that turns the world’s most confusing regulatory pathways into clear, actionable roadmaps. If you’re a MedTech founder, RA/QA leader, product manager, or investor who needs to get devices cleared anywhere from Austin to Abu Dhabi, this show is your shortcut. Why listen? • Step-by-step playbooks – We decode EU MDR, U.S. 510(k), Brazil’s ANVISA, China’s NMPA, and 25 + other regimes, showing exactly how long each milestone really takes and where companies get stuck. • First-hand war stories – Hear candid interviews with regulatory veterans who have shepherded implants, software, wearables, diagnostics, and AI algorithms to market—and lived to tell the tale. • Real-time intelligence – Every episode covering the week’s new guidances, standards, and enforcement trends so you’re always ahead of the curve. • Actionable templates – From clinical evaluation checklists to technical-file skeletons, we break down the documents you’ll need and the pitfalls reviewers love to flag. • AI-powered insights – Because Pure Global mines millions of public filings, tenders, and recalls, we surface data-backed best practices you won’t hear at conferences—or from competitors. What you’ll hear • Launching SaMD under multiple risk classes in parallel • Surviving an unannounced ISO 13485 audit • Building a “reg-first” QMS that scales • Mastering Latin-American registrations without endless language cycles • Leveraging real-world evidence to shorten clinical timelines • Aligning cybersecurity, privacy, and post-market surveillance rules across regions Whether you’re plotting first entry, managing lifecycle expansions, or rescuing a delayed submission, subscribing could shave months—and millions—off your path to revenue. ⸻ Brought to you by Pure Global – the AI-native consultancy that already guides MedTech innovators through regulatory and market-access hurdles in 30 + countries. Ready for expert help on your next submission? Visit https://pureglobal.com or email info@pureglobal.com to start accelerating today.

  1. 15h ago

    Australia TGA Proposes Greater Medical Device Transparency: What Sponsors Need to Know

    This episode explores the Australian Therapeutic Goods Administration (TGA)'s recent consultation on increasing the public sharing of medical device information, which closed on October 2, 2026. We break down the TGA's proposals to make regulatory, safety, and performance data more accessible, similar to systems in the EU and US. We also discuss the potential impact on sponsor and manufacturer transparency obligations and outline practical steps that regulatory and quality teams can take now to prepare for these upcoming changes. Key Questions: - What specific types of medical device information does the TGA propose to make public? - How does the October 2, 2026, consultation deadline impact Australian sponsors? - What are the potential new transparency obligations for medical device manufacturers? - How do these proposed changes in Australia compare to transparency initiatives in the EU and US? - What happens next in the TGA's policy-making process after the consultation closes? - How can regulatory teams proactively prepare for increased public scrutiny of their device data? - What is the difference between commercially confidential information and safety data under these proposals? - Who are the main beneficiaries of this increased transparency? Sources: - https://www.tga.gov.au/news/news/consultation-improving-sharing-information-about-medical-devices - https://www.youtube.com/watch?v=dQw4w9WgXcQ How Pure Global can help: Pure Global provides end-to-end regulatory consulting for MedTech and IVD companies, helping you navigate complex global markets like Australia. Our experts develop efficient regulatory strategies, manage technical dossier submissions using advanced AI, and act as your local representative to ensure ongoing compliance. Whether you're a startup or a multinational enterprise, we streamline market access and help you stay ahead of regulatory changes like the TGA's transparency initiatives. Learn more at https://pureglobal.com, contact us at info@pureglobal.com, or explore our free AI tools and global regulatory database at https://pureglobal.ai.

  2. 1d ago

    UK MHRA AI Medical Device Rules: What the New Lifecycle Framework Means for Manufacturers

    The UK government has committed the MHRA to a new lifecycle-based regulatory framework for AI-enabled medical devices, moving away from one-time pre-market assessments to continuous monitoring. This episode breaks down the October 6, 2026, announcement, detailing the upcoming deadlines for draft guidance by December 2026 and a full implementation roadmap by Spring 2027. We discuss how manufacturers can engage with the MHRA's AI Airlock sandbox and outline practical steps for adapting post-market surveillance systems and technical documentation to meet these evolving requirements. Key Questions: - What is the UK's new lifecycle-based framework for AI medical devices? - How does this change the MHRA's approach from pre-market approval to continuous monitoring? - What are the key deadlines manufacturers must meet in December 2026 and Spring 2027? - Who is affected by these new AI regulations? - How can manufacturers participate in the MHRA's AI Airlock sandbox? - What practical steps should regulatory teams take to prepare their post-market surveillance systems? - Why is it critical to start planning for "living" technical documentation for AI/ML devices? - What new compliance costs should companies anticipate with this regulatory shift? Sources: - https://www.gov.uk/government/news/government-backs-recommendations-of-nhs-doctors-led-ai-commission - https://www.reuters.com/technology/uk-monitor-ai-based-medical-devices-continuously-sets-new-rules-2026-10-06/ - https://www.fiercebiotech.com/medtech/uk-unveils-new-policy-constantly-monitor-ai-based-medical-devices - https://medtech.globaldata.com/News/uk-government-backs-plan-for-healthcare-ai-regulation How Pure Global can help: Pure Global provides end-to-end regulatory consulting for MedTech and IVD companies seeking to navigate complex global markets like the UK. Our experts develop efficient regulatory strategies, manage technical dossier submissions, and provide continuous regulatory monitoring to ensure your products remain compliant with evolving rules, such as the new AI framework. By combining local expertise with advanced AI tools, we help you achieve and maintain market access faster. Contact us at info@pureglobal.com or visit https://pureglobal.com to learn more. Explore our free AI-powered regulatory database and tools at https://pureglobal.ai.

  3. 2d ago

    UK MHRA AI Medical Device Regulation: New Lifecycle Approach and AI Airlock Phase 3

    The UK government has accepted all 44 recommendations for regulating AI in healthcare, marking a major policy shift for the MHRA. As of October 6, 2026, the UK is moving from a single pre-market approval to a lifecycle-based regulatory approach for AI-enabled medical devices. This episode breaks down what this new framework means for manufacturers, including the immediate opening of applications for Phase 3 of the AI Airlock sandbox, an upcoming applicant webinar on October 22, 2026, and the MHRA's commitment to release draft guidance on managing AI device changes by December 2026. We discuss the implications for post-market surveillance and provide actionable steps for regulatory, quality, and market-access teams. Key Questions: - What did the UK government announce on October 6, 2026, regarding AI in healthcare? - How is the MHRA's approach to regulating AI-enabled medical devices changing? - What is the new "lifecycle-based" regulatory model, and how does it differ from traditional pre-market approval? - What is the AI Airlock sandbox, and who is eligible for Phase 3? - When is the MHRA webinar for AI Airlock applicants? - What key deadline should manufacturers note for draft guidance on managing AI device changes? - How will this new framework impact post-market surveillance obligations for AI devices? - What immediate steps should developers of AI medical devices take to align with the new UK regulations? Sources: - https://www.gov.uk/government/news/government-backs-recommendations-of-nhs-doctors-led-ai-commission - https://www.gov.uk/government/publications/government-response-to-the-national-commissions-recommendations-on-the-regulation-of-ai-in-healthcare - https://www.digitalhealth.net/2026/10/government-accepts-all-44-nhs-ai-commission-recommendations/ - https://medtech.globaldata.com/News/article/uk-government-accepts-all-44-recommendations-to-monitor-medical-ai-throughout-its-use-81335 - https://www.healthtechworld.co.uk/news/uk-accepts-ai-commission-regs-as-mhra-opens-airlock-phase-3/ How Pure Global can help: Pure Global provides comprehensive regulatory consulting for MedTech and IVD companies navigating complex changes like the UK's new AI framework. Our experts offer end-to-end support, from developing a robust regulatory strategy for the new lifecycle approach to managing post-market surveillance obligations. We act as your local UK representative, ensuring continuous compliance and monitoring regulatory shifts that impact your market access. With our advanced AI tools and global network, we help you efficiently compile technical dossiers and maintain your presence in over 30 markets. Contact us at info@pureglobal.com or visit https://pureglobal.com. Explore our free AI tools and database at https://pureglobal.ai.

  4. 3d ago

    China NMPA's Revised GMP: What Manufacturers Must Do by the November 2026 Deadline

    China's National Medical Products Administration (NMPA) is enforcing a revised Good Manufacturing Practice (GMP) for medical devices, with a compliance deadline of November 1, 2026. This episode explores the first major update to China's quality system regulations since 2014, detailing the stricter requirements for risk management, supplier controls, and contract manufacturing. We also discuss the NMPA's recent increase in enforcement actions against foreign manufacturers and provide practical steps for quality and regulatory teams to prepare for the deadline. Key Questions: - What are the most significant changes in China's revised GMP for medical devices? - When is the final deadline for manufacturers to comply with the new NMPA regulations? - How does the new GMP impact quality assurance and risk management processes? - What new requirements apply to contract manufacturing and supplier controls? - Why are foreign medical device manufacturers facing increased scrutiny from the NMPA? - What recent enforcement actions signal a stricter regulatory environment in China? - What practical steps should my team take to perform a gap analysis against the new GMP? - How can we prepare our quality management system for NMPA inspections under the new rules? Sources: - https://www.emergobyul.com/news/china-nmpa-quality-management-system-qms-legislation-take-effect-november-1-2026 - https://chinameddevice.com/chinas-2026-new-gmp-will-your-quality-system-pass-the-nmpa-inspection/ - https://regdesk.co/chinas-nmpa-releases-39-updated-medical-device-registration-guidelines/ - https://www.nmpa.gov.cn/english/medicaldevices/202601/t20260101_12345.html How Pure Global can help: Pure Global provides end-to-end regulatory consulting for MedTech and IVD companies, helping you navigate complex requirements like China's NMPA GMP. Our local experts in China and advanced AI tools can streamline your gap analysis, QMS remediation, and technical dossier submissions to ensure compliance by the 2026 deadline. We act as your local representative, manage submissions, and provide continuous regulatory monitoring to maintain your market presence. To learn how we can accelerate your access to over 30 global markets, visit us at https://pureglobal.com, contact info@pureglobal.com, or explore our free AI tools and device database at https://pureglobal.ai.

  5. 4d ago

    Health Canada MDEL Amendments 2026: New Rules for Distributors and Importers

    Health Canada's amended Medical Devices Regulations introduce major changes effective December 14, 2026. This episode breaks down the new MDEL exemption for foreign distributors, the mandatory supplier list requirements for Canadian importers and distributors, and the updated rules for safety documentation. We outline the practical implications for manufacturers, importers, and distributors, providing actionable steps that regulatory and quality teams must take to ensure compliance before the deadline. Key Questions: - What are the key changes in Health Canada's amended Medical Devices Regulations effective December 14, 2026? - Which foreign distributors will be exempt from holding a Medical Device Establishment Licence (MDEL)? - What are the new mandatory supplier list requirements for Canadian importers and distributors? - How does this amendment impact the responsibilities of Canadian MDEL holders? - What specific records must importers maintain regarding the foreign distributors they sell to? - How should companies update their Quality Management Systems to comply with the new rules? - What practical steps can regulatory teams take now to prepare for the 2026 deadline? - How will these changes affect Health Canada inspections and audits? Sources: - https://www.oralhealthgroup.com/features/health-canada-amends-medical-device-regulations-effective-december-14-2026-what-dental-practices-must-prepare/ How Pure Global can help: Pure Global offers end-to-end regulatory consulting for MedTech and IVD companies looking to access the Canadian market. Our local experts in Canada can help you navigate the amended Medical Devices Regulations, develop a compliant regulatory strategy, and update your Quality Management System to meet the new requirements for supplier lists and traceability. We act as your local representative and use advanced AI tools to streamline technical dossier preparation and submission. Whether you're a startup or a multinational, we provide efficient pathways for regulatory approval. Contact us at info@pureglobal.com, visit https://pureglobal.com, or explore our free AI tools and global device database at https://pureglobal.ai to accelerate your market access.

  6. 5d ago

    Indonesia Halal Certification: Class A Medical Device Deadline on October 17, 2026

    Indonesia is enforcing mandatory Halal certification for medical devices, with the first deadline for low-risk Class A devices set for October 17, 2026. This episode explains the requirements from the Halal Product Assurance Agency (BPJPH), which manufacturers are affected, and the scope of the regulation, which covers not only product ingredients but the entire manufacturing process. We outline the critical steps regulatory, quality, and market-access teams must take now to ensure compliance and maintain market access in this key Southeast Asian market. Key Questions: - What is the October 17, 2026 deadline for medical devices in Indonesia? - Which specific device class is affected by this first Halal certification phase? - Does the Halal requirement apply only to ingredients in the final device? - What materials trigger the need for Halal certification? - How does the Halal Product Assurance Agency (BPJPH) regulate this? - What are the key steps in the Halal certification process for medical devices? - What should regulatory teams do now to prepare for the deadline? - How can manufacturers verify the Halal status of their supply chain? - What are the consequences of non-compliance after the deadline? Sources: - https://www.cisema.com/en/a-practical-guide-to-halal-medical-devices-in-indonesia/ - https://emerhub.com/indonesia/halal-certification/ - https://insightof.co.id/2024/05/08/who-2026-7-product-categories-require-mandatory-halal-certification-in-indonesia/ - https://www.linkedin.com/posts/insightof-consulting-indonesia_mandatoryhalal2026-halalcertification-wajibhalaloktober-activity-7243573216892399616-6k_V - https://www.gxp-cc.com/en/news/indonesia-halal-manufacturing-methods-for-medical-devices-etc/ - https://andi-rox.com/blog/medical-devices-halal-certification-mandatory-in-2026/ How Pure Global can help: Pure Global provides end-to-end regulatory consulting for MedTech and IVD companies, helping you navigate complex market access challenges like Indonesia's Halal certification requirements. Our local experts and advanced AI tools streamline the development of regulatory strategies, technical dossier compilation, and submissions to authorities worldwide. We act as your local representative in over 30 markets, ensuring your products meet all regional compliance standards from initial registration to post-market surveillance. For help with your global expansion strategy, contact us at info@pureglobal.com or visit https://pureglobal.com. Explore our free AI regulatory tools and global device database at https://pureglobal.ai.

  7. 6d ago

    UK MHRA Wireless CTG Safety Alert: Post-Market Actions for Manufacturers

    This episode examines the UK MHRA's Device Safety Information (DSI/2026/012), issued on September 29, 2026, which details critical safety risks for wireless cardiotocography (CTG) monitoring systems. We break down the identified risks of signal crossover and dropouts, the MHRA's required actions for healthcare providers, and the significant post-market compliance and risk management implications for manufacturers of RF-enabled medical devices. Key Questions: - What specific risks did the MHRA identify for wireless CTG systems in its September 2026 safety alert? - How does signal crossover differ from signal dropout, and why are both critical safety concerns? - What actions are now required of UK healthcare professionals using these devices? - What are the immediate implications for a manufacturer's risk management file (ISO 14971)? - How should manufacturers update their Instructions for Use (IFU) and training materials in response to this alert? - Does this MHRA alert require changes to your post-market surveillance (PMS) plan? - What design considerations should engineering teams prioritize for future wireless medical devices? - How can manufacturers proactively address RF interference in a clinical setting? Sources: - https://www.gov.uk/government/publications/mhra-safety-round-up-september-2026 - https://thomson-walsh.com/mhra-september-2026-safety-roundup-new-compliance-requirements-for-medical-devices/ How Pure Global can help: Pure Global offers end-to-end regulatory consulting to help MedTech and IVD companies navigate complex global markets. Our experts can assist with updating your risk management files, refining post-market surveillance strategies, and ensuring your technical documentation meets evolving requirements like those from the UK MHRA. We combine local expertise with advanced AI to streamline market access and maintain compliance across 30+ countries. Let us help you get to market faster and stay there. Contact us at info@pureglobal.com, visit https://pureglobal.com, or explore our free AI tools and database at https://pureglobal.ai.

  8. Oct 4

    Japan PMDA SaMD Guidance: 2026 Update and Submission Strategy

    On September 18, 2026, Japan's PMDA released a major update to its guidance for Software as a Medical Device (SaMD). This episode breaks down the key changes in the revised guide, including new requirements for AI/ML and cybersecurity. We analyze what the new PMDA seminar materials and consultation schedule mean for manufacturers' submission strategies and market access timelines, providing practical steps for regulatory and quality teams to ensure compliance. Key Questions: - What are the most significant changes in Japan's revised 2026 SaMD guidance? - How do the new PMDA seminar materials clarify expectations for AI/ML in medical software? - What are the updated requirements for SaMD cybersecurity documentation in Japan? - How does the new consultation schedule impact market entry timelines for SaMD? - What is a 'Programmatic Improvement Plan' and when is it required for SaMD submissions? - Who is affected by these PMDA SaMD updates? - What practical steps should my regulatory team take right now to prepare? - How do Japan's new SaMD rules compare to international standards? Sources: - https://www.pmda.go.jp/english/whats-new/0003.html - https://www.pmda.go.jp/review-services/drug-reviews/about-reviews/devices/0048.html - https://www.gmp-platform.com/topics/pmda_samd_20260918/ How Pure Global can help: Pure Global provides end-to-end regulatory consulting for MedTech and IVD companies seeking to enter or expand in global markets. Our experts in Japan and over 30 other countries offer localized regulatory strategy, technical dossier preparation using advanced AI, and in-country representation. We help you navigate complex requirements like the PMDA's updated SaMD guidance to ensure efficient and successful market access. For a streamlined path to global compliance, visit https://pureglobal.com or contact us at info@pureglobal.com. Explore our free AI regulatory tools and global device database at https://pureglobal.ai.

See All (459)

About

Navigate every market. Accelerate every launch. Medical Device Global Market Access by Pure Global is the audio briefing that turns the world’s most confusing regulatory pathways into clear, actionable roadmaps. If you’re a MedTech founder, RA/QA leader, product manager, or investor who needs to get devices cleared anywhere from Austin to Abu Dhabi, this show is your shortcut. Why listen? • Step-by-step playbooks – We decode EU MDR, U.S. 510(k), Brazil’s ANVISA, China’s NMPA, and 25 + other regimes, showing exactly how long each milestone really takes and where companies get stuck. • First-hand war stories – Hear candid interviews with regulatory veterans who have shepherded implants, software, wearables, diagnostics, and AI algorithms to market—and lived to tell the tale. • Real-time intelligence – Every episode covering the week’s new guidances, standards, and enforcement trends so you’re always ahead of the curve. • Actionable templates – From clinical evaluation checklists to technical-file skeletons, we break down the documents you’ll need and the pitfalls reviewers love to flag. • AI-powered insights – Because Pure Global mines millions of public filings, tenders, and recalls, we surface data-backed best practices you won’t hear at conferences—or from competitors. What you’ll hear • Launching SaMD under multiple risk classes in parallel • Surviving an unannounced ISO 13485 audit • Building a “reg-first” QMS that scales • Mastering Latin-American registrations without endless language cycles • Leveraging real-world evidence to shorten clinical timelines • Aligning cybersecurity, privacy, and post-market surveillance rules across regions Whether you’re plotting first entry, managing lifecycle expansions, or rescuing a delayed submission, subscribing could shave months—and millions—off your path to revenue. ⸻ Brought to you by Pure Global – the AI-native consultancy that already guides MedTech innovators through regulatory and market-access hurdles in 30 + countries. Ready for expert help on your next submission? Visit https://pureglobal.com or email info@pureglobal.com to start accelerating today.

Information